The Triple-Aim in Optimized SRS Series
rule


Thank you for registering to attend the webinar. A confirmation email has been sent to you.

Use the links below to register for the other webinars in The Triple-Aim in Optimized SRS - A Four Part Series.

   
 
JULY 7, 2020
12:00PM ET / 9:00AM PT

Presented by Michael McDermott, MD & Joseph A. Bovi, MD


An engaging review of Triple-Aim in SRS means in context to some of the classical indications for intracranial radiosurgery. Drs. McDermott & Bovi will highlight some of the unique treatment flexibility and workflow advantages of Leksell Gamma Knife Icon as clinicians move away from whole brain radiation and linac-based treatment approaches.

   
   
 
JULY 21, 2020
12:00PM ET / 9:00AM PT

Presented by Magda Martir, PhD, DABR


Learn how Leksell Gamma Knife Icon uniquely meets the strict standards of intracranial SRS while ensuring reliability and minimal QA requirements.


Elekta has applied to CAMPEP for approval of 1.0 MPCEC hours under Program Director, Paul Naine.

   
   

AUGUST 4, 2020
12:00PM ET / 9:00AM PT

Presented by Jonas Fontenot, PhD


A new and differentiated technology is only beneficial when you can reach your target patient population to their advantage. Gain insights on how one Elekta customer built a successful program and glean ideas on how to help grow existing programs as well.

   
   

AUGUST 18, 2020
12:00PM ET / 9:00AM PT

Presented by Stephanie Kriston


The final installment of this four-part series will focus on the current state of reimbursement policy for stereotactic radiosurgery and the likely impact of the radiation oncology alternative payment model from CMS.

   

 
 
 
 
Through precision radiation medicine, Elekta is helping clinicians focus where it matters, empowering them to protect the moments that matter for their patients.

Member login  
rule
SponsorAllianceInfoGraphic














Like our Facebook Page   
Join our Facebook Group
Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus

Journal of Neuro-Oncology
Join our Mailing List
divider